Skip to main content
. 2020 Mar 6;2020(2):hoaa005. doi: 10.1093/hropen/hoaa005

Table I. Description of study variables by data source.

CARTR Plus Reabstracted Data
Variable N % Mean SD Median IQR N % Mean SD Median IQR
Intake of patient
 Patient age (years) 876 35.5 4.63 35 (32–39) 876 35.5 4.66 35 (32–39)
 Oocyte provider age (years) 860 34.2 4.58 31 (34–38) 874 34.7 7.06 34 (31–38)
 Reason for treatment cycle
  Diminished ovarian reserve
   Yes 149 17.0 150 17.1
   No 727 83.0 726 82.9
  Advanced female age
   Yes 187 21.4 125 14.3
   No 689 78.7 751 85.7
 FSH (IU/L) 509 7.20 3.59 6.70 (5.20–8.00) 734 6.81 2.95 6.30 (5.00–7.90)
 AFC (# follicles) 362 16.2 11.8 13.5 (8.00–21.0) 583 16.3 11.2 14.0 (9.00–21.0)
 AMH (ng/dL)* 77 2.20 2.14 1.30 (0.90–2.80) 202 2.46 2.56 1.60 (0.80–3.30)
Stimulation
 Cycle type
  IVF 607 69.3 602 68.7
  FET 245 28.0 245 28.0
  Frozen oocyte IVF 14 1.60 18 2.05
  Oocyte banking 10 1.14 11 1.26
 Cancelled cycle
  Yes 60 6.85 62 7.08
  No 816 93.2 814 92.9
 Reason for cancelled
  Low ovarian response 47 78.3 38 61.3
  Premature ovulation 3 5.00 3 4.84
  Other 10 16.7 10 16.1
  Missing 0 0.00 11 17.7
Retrieval
 Oocyte origin
  Fresh own oocytes 672 82.4 750 92.1
  Fresh donor oocytes 35 4.29 39 4.79
  Other 3 0.37 23 2.83
  Missing 106 13.0 2 0.25
Embryo transfer
 Embryo transfer
  Yes 655 80.3 654 80.3
  No 152 18.6 160 19.7
  Missing 9 1.10 0 0.00
 ET day 655 2.57 2.12 647 4.39 1.16
  Fresh cycles 418 4.02 1.09 5.00 (3.00–5.00) 418 4.00 1.10 5.00 (3.00–5.00)
   2 26 6.22 27 6.46
   3 166 39.7 168 40.2
   5 225 53.8 222 53.1
   6 1 0.24 1 0.24
  Frozen cycles 237 0.00 0.00 229 5.10 0.93 5.00 (5.00–6.00)
   2 0 1 0.42
   3 0 21 8.90
   4 0 13 5.51
   5 0 120 50.9
   6 0 69 29.2
   >6 0 5 2.11
  Missing 7 2.97
 # embryos transferred
   1 362 55.3 362 55.4
   2 273 41.7 273 41.7
   3 17 2.60 16 2.45
   4 3 0.46 3 0.46
 eSET or eDET
  Yes 387 59.1 475 72.6
  No 268 40.9 177 27.1
  Missing 0 0.00 2 0.31
Embryology
 Embryo cryopreservation
  IVF
   Vitrification 267 94.0 267 94.0
   Slow-freeze 17 5.99 16 5.63
   Mixed 0 0.00 1 0.35
  FET
   Vitrification 142 58.0 194 79.2
   Slow-freeze 20 8.16 49 20.0
   Mixed 0 0.00 1 0.41
   Missing 83 33.9 1 0.41
 # embryos thawed 245 1.95 1.76 1.00 (1.00–2.00) 244 1.95 1.77 1.00 (1.00–2.00)
 # embryos utilizable after thaw 245 1.47 0.99 1.00 (1.00–2.00) 244 1.46 0.92 1.00 (1.00–2.00)
Pregnancy
 Pregnancy type
  Not pregnant 522 59.6 519 59.3
  Biochemical 45 5.14 52 5.94
  Clinical intrauterine 285 32.5 289 33.0
  Other 2 0.23 2 0.23
  Unknown 22 2.51 14 1.60
 # fetal sac
  1 221 77.5 222 76.8
  2 63 22.1 62 21.5
  3 1 0.35 2 0.69
  Missing 0 0.00 3 1.04
 # fetal heart
  0 26 9.12 28 9.69
  1 202 70.9 206 71.3
  2 56 19.7 52 18.0
  3 1 0.35 1 0.35
  Missing 0 0.00 2 0.69
 Chorionicity
  1 4 5.97 5 6.15
  2 59 88.1 45 69.2
  3 1 1.49 1 1.54
  Missing 3 4.48 15 23.1

AFC: antral follicle count, AMH: anti-Müllerian hormone, CARTR Plus: Canadian Assisted Reproductive Technologies Register Plus, eDET: elective double embryo transfer, eSET: elective single embryo transfer, ET: embryo transfer, FET: frozen embryo transfer, IQR: interquartile range, N: Number or patients

*AMH levels were converted from pmol/L to ng/dL using a conversion factor of 7.14 (Almog et al., 2011)

There was an error in data entry which was recoded as missing